Apogee Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $8.54M, a 2122.92% increase year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $4.32M, a 594.53% increase year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $356.00K, a 7.05% decline year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $384.00K, a 2642.86% increase year-over-year.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $5.30M, a 522.07% increase from fiscal 2024.
- Apogee Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $852.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $8.54M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $4.32M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | $5.30M 10-K · filed 2026-03-02 | |
| 2025-09-30 | $356.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $384.00K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $622.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $852.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $383.00K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $14.00K 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $24.00K 10-Q · filed 2025-11-10 |